Manguda, Monib C.

HRN: 28-19-21  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/12/2026
CEFTRIAXONE 1G (VIAL)
03/12/2026
03/19/2026
IV
2g
OD
Inguinal Hernia
Pending Pharmacy Acceptance 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Intra-abdominalProphylaxis    Compliance to guidelines: